ABBOTT NORGE AS

Operating

Å drive handel, produksjon, forskning, utvikling og markedsføring av produkter og produksjonsteknikker innen bioteknologi, deltakelse i andre selskaper, samt å yte administrative, operasjonelle, finansielle, forretningsmessige, forskningsmessige eller industrielle tjenester til enhver tredjepart, aksjeeier, datterselskap, tilknyttet selskap, herunder også lån, forskudd og garantier, samt annen virksomhet som hermed er forbundet.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO: KA
Karl Andreas Almroth1974
Chairman of the board: BF
Björn Fredrik Anders Björnulfson1972
Years since formation: 31 years; since Mar 12, 1995
Type: Limited company
VAT registered: Yes
Number of employees: 51

Ownership

Number of shares and share classes: 1,000; 1 share class
Total number of shareholders: 1; person
Belongs to group of

Financials

Total operating income 2025: 604,043,194; NOK
Annual total result 2025: 29,450,540; NOK
Total equity 2025: 162,179,720; NOK

Last update: Aug 4, 2026

Management

Management / administration

Name	Role	Shares
KA Karl Andreas Almroth 1974	Managing Director/CEO	-

Board

Name	Role	Shares
BF Björn Fredrik Anders Björnulfson 1972	Chairman	-
BJ Bradley Jay Slater 1969	Board Member	-

Others

Name	Role	Shares
E ERNST & YOUNG AS	Auditor	-

Last update: Nov 1, 2024

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
SA Sa Abbott	Ordinary shares	1,000	100 %

Shares owned by the ABBOTT NORGE AS

Name	Share class	Total number of shares	Share
A ABBOTT MEDICAL NORWAY AS	Ordinary shares	100	100 %

Last update: Jun 2, 2025

Group structure

ABBOTT NORGE AS
Total operating income 2025: NOK 604,043,194
Operating profit 2025: NOK 31,320,038
Employees: 51

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	604,043,194	571,134,169	508,558,955	460,488,699	483,964,000
Annual Total Result	29,450,540	20,942,574	25,777,806	16,139,071	13,217,000
Total assets	263,990,389	284,072,680	210,168,955	181,714,679	160,287,000
Total liabilities	101,810,669	151,343,500	98,382,349	95,705,878	90,417,000
Total equity	162,179,720	132,729,180	111,786,606	86,008,800	69,870,000

P&L

Year	2025	2024	2023	2022	2021
Total operating income	604,043,194	571,134,169	508,558,955	460,488,699	483,964,000
Total operating costs	572,723,156	549,156,736	477,949,804	439,636,984	465,866,000
Operating result	31,320,038	21,977,433	30,609,151	20,851,715	18,098,000
Financial income/costs	6,730,797	5,231,400	2,767,747	230,678	-970,000
Profit before tax	38,050,835	27,208,833	33,376,898	21,082,393	17,128,000
Total tax & extraordinary income/cost	8,600,295	6,266,259	7,599,092	4,943,322	3,911,000
Annual Total Result	29,450,540	20,942,574	25,777,806	16,139,071	13,217,000

Balance overview

Year	2025	2024	2023	2022	2021
Total fixed assets	34,732,547	30,017,378	32,588,280	35,611,556	36,114,000
Total current assets	229,257,842	254,055,302	177,580,675	146,103,123	124,173,000
Total assets	263,990,389	284,072,680	210,168,955	181,714,679	160,287,000
Short term debt	101,616,178	150,684,579	97,795,424	95,109,576	89,993,000
Long term debt	194,491	658,921	586,925	596,302	424,000
Total liabilities	101,810,669	151,343,500	98,382,349	95,705,878	90,417,000
Contributed capital	14,462,978	14,462,978	14,462,978	14,462,978	14,463,000
Retained earnings	147,716,742	118,266,202	97,323,628	71,545,822	55,407,000
Total equity	162,179,720	132,729,180	111,786,606	86,008,800	69,870,000
Total equity and liabilities	263,990,389	284,072,680	210,168,955	181,714,678	160,287,000

Classification

21st company classification

BETA

Industrial large enterprise

ABBOTT NORGE AS957 212 158

ABBOTT NORGE AS

Keywords

Organization

Ownership

Financials

Management

Management / administration

Board

Others

Ownership

Company shareholders

Shares owned by the ABBOTT NORGE AS

Group structure

Financials

Summary

P&L

Balance overview

Classification